Efficacy Evaluation of the Esophagogastric Junction Exposure Obtained by the Flexible Liver Retractor in Gastroplasty

NCT ID: NCT02926885

Last Updated: 2016-10-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-08-31

Study Completion Date

2016-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluation of a new technique of liver retraction for the exposure of the His angle in gastric bypass Roux-en-Y surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Obesity is a chronic disease of clinical treatment initially, but with precise surgical indications regulated by national and international health organizations. Among the surgical techniques, the gastric bypass Roux-en-Y is considered the "gold standard" for its efficiency and low morbidity and mortality. In gastric laparoscopic surgery it is necessary to move the liver in order to ensure adequate working space and a good view. Conventional laparoscopic retractors surgery are generally coarse, require an additional incision for its installation, or handling by an assistant during surgery and involve risk of liver injury. The objective of this study was to evaluate the efficacy of a flexible liver retractor in the exposure of the His angle in Roux-en-Y gastric bypass for morbid obesity. This was a prospective, controlled, open and comparative study, with 100 patients randomly divided into two groups (conventional and flexible retractor), with medical indication for bariatric surgery. Data were recorded during surgery in both groups for comparison of the two hepatic retraction techniques.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CONVENTIONAL LIVER RETRACTOR DEVICE

USE OF CONVENTIONAL LIVER RETRACTOR FOR THE LAPAROSCOPIC ROUX-EN-Y GASTRIC BYPASS SURGERY

Group Type ACTIVE_COMPARATOR

CONVENTIONAL LIVER RETRACTOR DEVICE

Intervention Type DEVICE

LIVER RETRACTION FOR THE EXPOSURE OF THE ESOPHAGOGASTRIC JUNCTION USING CONVENTIONAL RETRACTOR DEVICE

LAPAROSCOPIC ROUX-EN-Y GASTRIC BYPASS SURGERY

Intervention Type PROCEDURE

LAPAROSCOPIC ROUX-EN-Y GASTRIC BYPASS SURGERY

FLEXIBLE LIVER RETRACTOR DEVICE

USE OF THE FLEXIBLE LIVER RETRACTOR FOR THE LAPAROSCOPIC ROUX-EN-Y GASTRIC BYPASS SURGERY

Group Type EXPERIMENTAL

FLEXIBLE LIVER RETRACTOR DEVICE

Intervention Type DEVICE

LIVER RETRACTION FOR THE EXPOSURE OF THE ESOPHAGOGASTRIC JUNCTION USING FLEXIBLE LIVER RETRACTOR DEVICE

LAPAROSCOPIC ROUX-EN-Y GASTRIC BYPASS SURGERY

Intervention Type PROCEDURE

LAPAROSCOPIC ROUX-EN-Y GASTRIC BYPASS SURGERY

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CONVENTIONAL LIVER RETRACTOR DEVICE

LIVER RETRACTION FOR THE EXPOSURE OF THE ESOPHAGOGASTRIC JUNCTION USING CONVENTIONAL RETRACTOR DEVICE

Intervention Type DEVICE

FLEXIBLE LIVER RETRACTOR DEVICE

LIVER RETRACTION FOR THE EXPOSURE OF THE ESOPHAGOGASTRIC JUNCTION USING FLEXIBLE LIVER RETRACTOR DEVICE

Intervention Type DEVICE

LAPAROSCOPIC ROUX-EN-Y GASTRIC BYPASS SURGERY

LAPAROSCOPIC ROUX-EN-Y GASTRIC BYPASS SURGERY

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Between 18 - 65 years, both genders, with indication of bariatric surgery according to IFSO criteria.
* Agreed to participate and signed informed consent form.

Exclusion Criteria

* Patients who did not agree to participate and / or any other condition that the investigator judged relevant for not participating in the study were excluded.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

RODRIGO FEITOSA DE ALBUQUERQUE LIMA BABADOPULOS

MD, GASTRIC SURGEON

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rodrigo Babadopulos, MD

Role: PRINCIPAL_INVESTIGATOR

Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Nucleo de Pesquisa e Desenvolvimento da Universidade Federal do Ceara

Fortaleza, CearĂ¡, Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RB001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.